Growth Metrics

Insulet (PODD) Capital Expenditures Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -17.56%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 34.96%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -6.72%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -5.35%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 15.89%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -47.73%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -11.95%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -43.42%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 27.22%
10 Insulet 10.37 Bn 9.89 Bn 529.10 Mn -17.89%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -17.89%
Dec 31, 2025 -69.96%
Sep 30, 2025 -118.35%
Jun 30, 2025 -119.11%
Mar 31, 2025 -44.34%
Dec 31, 2024 241.80%
Sep 30, 2024 32.84%
Jun 30, 2024 43.31%
Mar 31, 2024 110.48%
Dec 31, 2023 -1,612.00%
Sep 30, 2023 617.86%
Jun 30, 2023 248.89%
Mar 31, 2023 238.71%
Dec 31, 2022 103.61%
Sep 30, 2022 -89.74%
Jun 30, 2022 -90.76%
Mar 31, 2022 -24.39%
Dec 31, 2021 -70.27%
Sep 30, 2021 3.02%
Jun 30, 2021 12.47%
Mar 31, 2021 -51.19%
Dec 31, 2020 -126.51%
Sep 30, 2020 268.06%
Jun 30, 2020 546.39%
Mar 31, 2020 -33.86%
Dec 31, 2019 22,178.66%
Sep 30, 2019 109.35%
Jun 30, 2019 -113.81%
Mar 31, 2019 -27.43%
Dec 31, 2018 -97.35%
Sep 30, 2018 -980.72%
Jun 30, 2018 424.54%
Mar 31, 2018 -31.85%
Dec 31, 2017 793.02%
Sep 30, 2017 -34.25%
Jun 30, 2017 387.76%
Mar 31, 2017 712.63%
Dec 31, 2016 -16.43%
Sep 30, 2016 426.73%
Jun 30, 2016 976.47%
Mar 31, 2016 -27.29%
Dec 31, 2015 32.24%
Sep 30, 2015 -18.76%
Jun 30, 2015 -92.89%
Mar 31, 2015 101.48%
Dec 31, 2014 -5.63%
Sep 30, 2014 70.58%
Jun 30, 2014 120.66%
Mar 31, 2014 101.78%
Dec 31, 2013 35.77%
Sep 30, 2013 -61.13%
Jun 30, 2013 -36.24%
Mar 31, 2013 -37.08%
Dec 31, 2012 -9.71%
Sep 30, 2012 42.98%
Jun 30, 2012 -4.24%
Mar 31, 2012 -41.35%
Dec 31, 2011 -21.97%
Sep 30, 2011 99.15%